UK implant company does not infringe McGhan patent
This article was originally published in Clinica
The UK High Court has thrown out a claim by McGhan Medical, the breast implant manufacturing division of Inamed, against a rival manufacturer and distributor. McGhan Medical's UK company attempted to block the manufacture and sale of silicone prostheses whose outer surface is roughened in order to minimise hard tissue deposition.
You may also be interested in...
Assessment work also isn’t slowing down, the new and generic drug office directors said in an interview, but approval data offers a note of concern.
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.